Abstract:Abstract Background Renal dysfunction (RD) is a predictor of adverse outcomes in patients with acquired heart failure (HF). Studies in adult congenital heart disease (ACHD) have demonstrated the link between RD and increased mortality. However, there is a paucity of data regarding the prognostic significance of RD in ACHD and HF. We assessed the impact of RD on outcomes in ACHD patients presenting with acute decompensated HF requiring intravenous (IV) diuresis in a tertiary centre between 2010–2021. Methods This was a retrospective analysis on RD and outcomes during the index hospital admission and after discharge. Chronic kidney disease (CKD) was defined as an eGFR <60mL/min/1.73 m2 using the MDRD equation. Cox regression analysis was used to identify predictors of death after discharge. Results We included 176 HF admissions, 76 (43.2%) female, age 47.7±14.5 years. Complex CHD was present in 50.6%. The most frequent underlying congenital heart defects were: transposition of the great arteries (including congenitally corrected, 19.9%), univentricular (14.2%), and tetralogy of Fallot (13.6%). Eisenmenger syndrome was present in 18.8%, a systemic right ventricle in 22.2%, 40.9% had pulmonary arterial hypertension (PAH), and 38.1% were cyanotic. At the time of the index admission 92 (52.3%) had RD (eGFR <60 mL/min/1.73 m2 and/or serum creatinine >88 μmol/L), 63 (38.2%) had a history of CKD. Patients with RD on admission were older (49.8 [42.3–60.9] vs. 46.0 [33.8–53.6] years, p=0.02) and more likely to have a history of arrhythmia (71.7% vs. 53.6%, p=0.02), but did not differ to those without RD in terms of diabetes mellitus or systemic hypertension. Admission BNP was higher in patients with RD (594 [258–1216] vs. 354 [158–633] ng/L, p=0.01). Patients with RD were more likely to have at least moderate systemic (31.8% vs. 11.8%, p=0.005) or pulmonary (58.4% vs. 36.4%, p=0.01) ventricular dysfunction. They were also more likely to have systemic ventricular dilatation (28.6% vs. 11.8%, p=0.02) or a larger RA area (29 [21–34] vs. 21 [16–31] cm2, p=0.008). Inpatients with RD required higher doses of IV furosemide (160 [80–200] vs. 80 [70–160] mg, p=0.03) and there was a trend for more frequent inotropic support (19.6% vs. 8.3%, p=0.06). In-hospital mortality was relatively low (4.5%), however, 94 (56.0%) patients died and 73 (43.5%) were rehospitalised for HF at a median follow-up of 2.8 [0.01–12.0] years. CKD (HR 2.43, 95% CI: 1.59–3.71, p<0.0001) and RD on admission (HR 1.7, 95% CI: 1.13–2.58, p=0.01) were strong predictors of death (Figure 1). On multivariable Cox analysis, PAH, CKD, and peak inpatient diuretic dose remained predictive of mortality. Conclusions ACHD patients admitted with acute decompensated HF are a high-risk cohort for acute re-admission and mortality. Preexisting RD and need for high dose IV diuretics conveys an even worse prognosis. Earlier interventions based on evidence of RD in ACHD may modulate this spiral trajectory and warrants further investigation. Funding Acknowledgement Type of funding sources: None.

Urinary cell cycle arrest biomarkers and diuretic efficiency in acute heart failure

Effect of Urine Output on the Predictive Precision of NephroCheck in On-Pump Cardiac Surgery With Crystalloid Cardioplegia: Insights from the PrevAKI Study

The dynamics of urine sodium concentration after intra-venous furosemide in patients with acute heart failure

Prognostic value of glomerular filtration changes versus natriuretic response in decompensated heart failure with reduced ejection

Trajectory of urine albumin-creatinine ratio in patients with acute heart failure (TACRAHF study)

Renal function and natriuresis‐guided diuretic therapy – a pre‐specified analysis from the PUSH‐AHF trial

Absence of Kidney Tubular Injury in Patients With Acute Heart Failure With Acute Kidney Injury

Worsening renal function in acute heart failure in the context of diuretic response

Effect Of Urinary Kidney Injury Molecule-1 Levels On Short-Term Prognosis Of Chronic Heart Failure

Urinary Biomarkers At The Time Of Aki Diagnosis As Predictors Of Progression Of Aki Among Patients With Acute Cardiorenal Syndrome

Spot urine sodium‐to‐creatinine ratio surpasses sodium in identifying poor diuretic response in acute heart failure

Pre-Discharge Urinary Albumin-Creatinine Ratio as a Predictor of Post-Hospitalization Major Adverse Cardiovascular Events (MACEs) Due to Acute Heart Failure

Clinical Usefulness of Urinary Liver Fatty Acid-Binding Protein Excretion for Predicting Acute Kidney Injury during the First 7 Days and the Short-Term Prognosis in Acute Heart Failure Patients with Non-Chronic Kidney Disease

A review regarding the article 'Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure'

Association of renal circulation at acute phase with decongestion level at discharge in patients admitted for acute decompensated heart failure

Relationship between clinical congestion and worsening renal function after intravenous initiation of furosemide in patients with acute heart failure

Novel biomarkers for prediction of acute kidney injury in acute heart failure

Effects of a diuretic adjustment algorithm protocol on heart failure admissions: A randomized clinical trial

Renal Dysfunction: a Predictor of Adverse Outcomes in ACHD Patients with Acute Decompensated Heart Failure

Utility of Urine Biomarkers and Electrolytes for the Management of Heart Failure

Short‐term prognostic implications of serum and urine neutrophil gelatinase‐associated lipocalin in acute heart failure: findings from the AKINESIS study